Captrust Financial Advisors Ionis Pharmaceuticals Inc Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $6,855 - $8,157	-158 Reduced 1.54%	10,108 $511,000
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $36,151 - $44,255	939 Added 10.07%	10,266 $465,000
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $4,549 - $5,676	-131 Reduced 1.39%	9,327 $382,000
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $2,350 - $2,884	-70 Reduced 0.73%	9,458 $338,000
Q4 2022 Feb 15, 2023	BUY	$37.12 - $46.52 $353,679 - $443,242	9,528 New	9,528 $359,000
Q2 2022 Aug 23, 2022	SELL	$31.71 - $43.0 $27,587 - $37,410	-870 Reduced 37.84%	1,429 $53,000
Q2 2022 Aug 16, 2022	BUY	$31.71 - $43.0 $35,483 - $48,117	1,119 Added 94.83%	2,299 $85,000
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $3,615 - $4,481	-121 Reduced 9.3%	1,180 $44,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $29,989 - $41,102	-1,171 Reduced 47.37%	1,301 $40,000
Q3 2021 Nov 16, 2021	BUY	$33.54 - $40.55 $19,319 - $23,356	576 Added 30.38%	2,472 $83,000
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $2,659 - $3,638	-77 Reduced 3.9%	1,896 $76,000
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $17,854 - $26,787	420 Added 27.04%	1,973 $89,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $4,872 - $6,349	104 Added 7.18%	1,553 $93,000
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $60,278 - $91,866	1,449 New	1,449 $68,000
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $26,709 - $32,373	-496 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $17,718 - $21,645	300 Added 153.06%	496 $30,000
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $9,561 - $13,265	154 Added 366.67%	196 $13,000
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $2,328 - $3,571	-44 Reduced 51.16%	42 $3,000
Q2 2018 Aug 13, 2018	BUY	$40.53 - $50.7 $3,485 - $4,360	86 New	86 $4,000
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $3,790 - $4,734	-86 Closed	0 $0
Q3 2017 Feb 16, 2018	BUY	$45.56 - $59.57 $3,918 - $5,123	86	86 $4,000

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$567 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$534 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$389 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$329 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$297 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account